AMPK is able to regulate a variety of pathological processes such as oxidative stress, excitotoxicity, and neuroinflammation during a stroke. Studies have shown that targeting AMPK can effectively modulate stroke pathology, but the exact mechanism of action remains controversial. Ace Therapeutics offers comprehensive services to develop stroke drugs targeting AMPK. With our expertise and quality service system, we can ensure the successful completion of your study.
Given the complex role of AMPK in stroke pathology, there is also a higher demand for developing stroke drugs based on AMPK. Therefore, Ace Therapeutics provides different screening platforms established for AMPK pathway targets to find potential stroke drug candidates.
After the initial validation of the obtained drug candidates, Ace Therapeutics conducted more in-depth study services of the obtained drug candidates in screening to elucidate their specific efficacy and mechanism of action in stroke treatment.
At the same time, we can tailor our research services exclusively to your research needs. If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.